Kristian Humer - 16 Apr 2024 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Financial Officer
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Kristian F. Humer
Issuer symbol
FHTX
Transactions as of
16 Apr 2024
Net transactions value
+$1,658,250
Form type
4
Filing time
17 Apr 2024, 16:01:57 UTC
Previous filing
12 Jul 2023
Next filing
13 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (Right to buy) Award $1,658,250 +275,000 $6.03 275,000 16 Apr 2024 Common Stock 275,000 $6.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on April 16, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.